SSwitzerland Read More Belite Bio gains Swiss orphan status for tinlarebant2026-05-18 Belite Bio (NASDAQ: BLTE) received orphan drug status from Swissmedic for tinlarebant in…
RRoche Read More Roche to present 45 ophthalmology studies at ARVO2026-04-30 Roche (OTCQX: RHHBY) will present more than 45 abstracts at ARVO 2026 (3–7…